drugset / Trial / NCT05849597

Dexmedetomidinine in the Prevention of Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery

NCT05849597

Phase 3 Recruiting 200 enrolled University of Novi Sad
RandomizedParallel-groupSingle-blindPrevention

Summary

This is a prospective, randomized, single blinded, controlled clinical trial designed to compare the clinical effects of sedation with dexmedetomidine versus propofol in patients undergoing cardiac surgery.

Timeline

Start
2022-03-01
Primary completion
2025-02
Completion
2025-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg
Subject Dexmedetomidine Other / unclassified 0.7 ug/kg
Comparator Propofol Small molecule 1 mg/kg
Comparator Propofol Small molecule 2 mg/kg

Indications